BIOPROMIC is an independent, privately held biotech company providing unique and high quality components for diagnostics and biotechnology, as well as consulting services helping partners in development of new techniques and tests.
In 2017 we opened our new R&D facility at Karolinska Institutet Science Park in Stockholm, Sweden.
WE ARE WORKING TO CHANGE THE FUTURE OF RAPID POINT-OF-CARE DIAGNOSTICS
A spectrum of Biopromic’s proprietary technologies allows us to develop simple -to -use and affordable tests for clinical and veterinarian settings.
We specialize in production of ultra-sensitive monoclonal antibodies targeted primarily against carbohydrate antigens derived from bacteria and viruses. We also produce a wide range of bacterial antigens and their analogs.